2025-12-31 - Analysis Report
Okay, here's a comprehensive analysis of Starbucks (SBUX) based on the provided data.

**1. Return Rate vs. S&P 500 (VOO)**

*   **Company Overview:** Starbucks Corp is a global coffeehouse company and roaster of specialty coffees.
*   **SBUX Cumulative Return:** 1.86%
*   **VOO Cumulative Return:** 102.21%
*   **Divergence:**
    *   Current: -101.6
    *   Relative Divergence: 2.9
*   **Analysis:** SBUX has significantly underperformed the S&P 500 (VOO) over the period.  The current divergence is substantial, indicating a considerable gap in returns.  The relative divergence of 2.9 suggests the current divergence is near the lower end of its historical range. This information should be interpreted with caution as past performance is not a guarantee of future returns.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha    | Beta   | Cap(B) |
|------------|----------|---------|----------|--------|--------|
| 2015-2017  | -1.0%    | 67.8%   | -30.0%   | -0.1   | 65.3   |
| 2016-2018  | 0.0%     | 64.5%   | -16.0%   | -0.1   | 73.2   |
| 2017-2019  | 52.0%    | 78.9%   | 30.0%    | 0.3    | 100.0  |
| 2018-2020  | 56.0%    | 80.2%   | 32.0%    | 0.4    | 121.7  |
| 2019-2021  | 24.0%    | 80.2%   | -23.0%   | 0.7    | 133.0  |
| 2020-2022  | -38.0%   | 80.2%   | -38.0%   | 0.3    | 112.8  |
| 2021-2023  | -51.0%   | 81.9%   | -52.0%   | -0.5   | 109.2  |
| 2022-2024  | -25.0%   | 81.9%   | -46.0%   | -0.6   | 103.8  |
| 2023-2025  | -9.0%    | 81.9%   | -76.0%   | 0.8    | 96.9   |

*   **CAGR:** The Compounded Annual Growth Rate is negative in most of the periods, indicating that the stock is not growing annually.
*   **MDD (Maximum Drawdown):** High MDD values consistently mean that the stock price has a lot of downward volatility and potential risk of high losses if the timing is not right.
*   **Alpha:** Negative Alpha values across most periods imply underperformance relative to the market.  A significant negative Alpha suggests the stock's returns are worse than what would be expected based on its Beta.
*   **Beta:** The Beta values fluctuate, indicating varying degrees of sensitivity to market movements. Values closer to 1 suggest the stock moves more or less in line with the market, while values significantly above or below 1 indicate higher or lower sensitivity, respectively.  The trend of beta has also varied throughout the years.
*   **Cap(B):** Market Cap has declined in recent years.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 85.25
*   **Previous Close:** 85.57
*   **Change:** -0.37
*   **5-day SMA:** 84.866
*   **20-day SMA:** 85.348
*   **60-day SMA:** 84.3147
*   **Analysis:** The stock price has slightly decreased recently.  The 5-day SMA is below the 20-day SMA, which is slightly above the 60-day SMA. This *could* indicate a short-term downward trend or consolidation, but the differences are minimal.

**3. RSI, PPO, and Divergence Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI:** 59.66 (Nearing Overbought)
*   **PPO:** -0.11 (Slightly Bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change:** -6.6 (Short-term decline)
*   **Expected Return (%):** -1843.0 (Negative Long-Term Outlook)
*   **Analysis:**
    *   The MRI suggests a high investment recommendation, which contradicts other indicators.
    *   The RSI value of 59.66 indicates that the stock is nearing overbought levels, indicating a reversal might happen in short term.
    *   The negative PPO suggests that SBUX is on a declining trend.
    *   The Hybrid Signal shows that it is safe to buy now, with 100% cash investment.
    *   The negative change in relative divergence confirms a short-term downward trend.
    *   The extremely negative expected return suggests a very pessimistic outlook for long-term investment in SBUX *relative to the S&P 500*. The price fluctuation also must be considered.

**4. Recent News & Significant Events:**

*   **Strike Fallout, NYC Settlement and Analyst Forecasts:** Potentially negative impacts of labor disputes and legal issues.
*   **MrBeast Partnership:** A potentially positive development that could attract new customers and boost brand awareness.
*   **Focus on Profitability and Customer Experience:** Indicates a strategic shift that could improve financial performance in the long run.
*   **Reduced Stock Position by Fort Washington:** Institutional selling pressure could negatively impact the stock price.
*   **Factors for 2026:**  Suggests potential future catalysts or challenges that investors should monitor.
*   **Quarterly Cash Dividend:** Generally a positive signal for investors, providing income.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (2.36)
*   **Target Price:** 94.13 (Indicates potential upside)
*   **Analysis:** Despite the recent underperformance, analysts generally have a positive outlook on SBUX, with a "Buy" consensus and a target price significantly above the current price. However, recent rating changes are unavailable, limiting insight into shifts in analyst sentiment.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-07-29 | 0.49 | 9.46 B$  |
| 2025-04-29 | 0.34 | 8.76 B$  |
| 2025-01-28 | 0.69 | 9.40 B$  |
| 2024-07-30 | 0.93 | 9.11 B$  |
| 2025-07-29 | 0.93 | 9.11 B$  |

*   **Analysis:** EPS has fluctuated over the periods, with the most recent value at 0.49. The revenue has also fluctuated, indicating some short-term volatility in Starbucks' business performance.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $9.57B     | 22.60%        |
| 2025-06-30   | $9.46B     | 22.80%        |
| 2025-03-31   | $8.76B     | 21.09%        |
| 2024-12-31   | $9.40B     | 24.49%        |
| 2024-09-30   | $9.07B     | 26.25%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30   | $-8.10B    | -1.65%   |
| 2025-06-30   | $-7.69B    | -7.26%   |
| 2025-03-31   | $-7.62B    | -5.04%   |
| 2024-12-31   | $-7.47B    | -10.45%  |
| 2024-09-30   | $-7.45B    | -12.21%  |

*   **Revenue:** Revenue has been relatively stable, with a slight upward trend.
*   **Profit Margin:** Profit margins have declined over the past few quarters.
*   **Equity:** Negative equity is a significant concern.
*   **ROE:** Negative ROE confirms the challenges in generating profits from equity.

**7. Comprehensive Analysis (Summary):**

*   **Underperformance:** SBUX has significantly underperformed the S&P 500, suggesting problems with company specific or market risks.
*   **Mixed Signals:** Technical indicators provide mixed signals. The MRI suggests investment is reasonable, while the negative change in relative divergence and the PPO indicate a downward trend.
*   **Negative Equity and ROE:** The combination of negative equity and negative ROE is a significant red flag.
*   **Analyst Optimism vs. Reality:** Analysts maintain a "Buy" rating, but the financial data paints a more concerning picture.
*   **News and Events:** Recent news presents a mixed bag of potentially positive (MrBeast partnership, focus on profitability) and negative (strike fallout, reduced stock position) developments.
*   **Conclusion:** SBUX presents a complex investment picture. While analysts are optimistic and the company is taking steps to improve profitability, the negative equity, declining profit margins, underperformance compared to the market, and mixed technical signals warrant caution. The company may need to take additional strategic actions to improve profitability and equity performance. Investment decisions should carefully weigh these factors.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.